At Aurinia Pharmaceuticals, we’re developing innovative products for patients living with debilitating diseases.
Voclosporin has the potential to be the first therapy approved for the treatment of lupus nephritis (LN) in the United States and Europe.
Aurinia is a global clinical stage biopharmaceutical company focused on developing and commercializing innovative products to treat serious diseases.
Join the World Lupus Federation for their 15th annual observance of World Lupus Day.
May 10, 2018 • 12:00am EDT
May 1, 2018 • 12:00am EDT
